New adjustable implant aims to stop leakage in women
NCT ID NCT04248283
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests a device called Adjustable Continence Therapy (ACT) for women with stress urinary incontinence caused by a weak urethral sphincter. The implant has two balloons placed near the bladder neck that can be adjusted after surgery to improve control. The study will enroll 167 women who have not gotten better with other treatments, and will measure changes in urine leakage and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Adjustable Continence Therapy (ACT) device
What this could lead to
If it works, this could offer a new, adjustable implant option for women with stress urinary incontinence who have not improved with other treatments.
What could go wrong
This is an early, single-arm study without a comparison group, so results may be less reliable. The implant requires surgery and carries risks like infection or device malfunction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY INCONTINENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHI Health Research Center
RECRUITINGOmaha, Nebraska, 68124, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Nantes
RECRUITINGNantes, 44000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital de la Conception - Marseille
RECRUITINGMarseille, 13005, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pitié Salpêtrière University Hospital Paris
RECRUITINGParis, 75013, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Colorado
RECRUITINGDenver, Colorado, 80045, United States
Contact Email: •••••@•••••
Contact
Contact